Endocrine alterations in primary Sjogren's syndrome: An overview

Journal of Autoimmunity

Volumn 39, Issue 4, 2012, Pages 354-358

  Mavragani, Clio P ^a   Fragoulis, George E ^a   Moutsopoulos, Haralampos M ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Adrenal; Endocrine; HPA axis; Prolactin; Sjogren's syndrome; Thyroid

Indexed keywords

ANDROGEN; CORTICOTROPIN; ESTROGEN; GROWTH HORMONE; PRASTERONE SULFATE; PROLACTIN; SOMATOMEDIN; STEROID 21 MONOOXYGENASE;

ADRENAL DISEASE; ANDROGEN DEFICIENCY; APOPTOSIS; B LYMPHOCYTE; ENDOCRINE SYSTEM; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; HYPOTHALAMUS HYPOPHYSIS THYROID SYSTEM; HYPOTHYROIDISM; IMMUNE RESPONSE; PATHOGENESIS; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW; SALIVARY GLAND; SJOEGREN SYNDROME; THYROID DISEASE;

ANDROGENS; AUTOANTIBODIES; AUTOANTIGENS; DEHYDROEPIANDROSTERONE SULFATE; ESTROGENS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; HYPOTHYROIDISM; PITUITARY-ADRENAL SYSTEM; PROLACTIN; SALIVARY GLANDS; SJOGREN'S SYNDROME; STEROID 21-HYDROXYLASE;

EID: 84869883266     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2012.05.011     Document Type: Review

References (58)

1. Mavragani C.P., Moutsopoulos H.M. The geoepidemiology of Sjogren's syndrome. Autoimmunity Reviews 2010, 9:A305-A310.
2. Karaiskos D., Mavragani C.P., Makaroni S., Zinzaras E., Voulgarelis M., Rabavilas A., et al. Stress, coping strategies and social support in patients with primary Sjogren's syndrome prior to disease onset: a retrospective case-control study. Annals of the Rheumatic Diseases 2009, 68:40-46.
3. Johnson E.O., Vlachoyiannopoulos P.G., Skopouli F.N., Tzioufas A.G., Moutsopoulos H.M. Hypofunction of the stress axis in Sjogren's syndrome. The Journal of Rheumatology 1998, 25:1508-1514.
4. Jessop D.S., Turner-Cobb J.M. Measurement and meaning of salivary cortisol: a focus on health and disease in children. Stress (Amsterdam, Netherlands) 2008, 11:1-14.
5. Miller B.E., Deutsch O., Redlich M., Konttinen Y.T., Benoliel R., Zaks B., et al. Sialochemistry and cortisol levels in patients with Sjogren's syndrome. Oral Diseases 2012, 18:255-259.
6. van der Goes M.C., Bossema E.R., Hartkamp A., Godaert G.L., Jacobs J.W., Kruize A.A., et al. Cortisol during the day in patients with systemic lupus erythematosus or primary Sjogren's syndrome. The Journal of Rheumatology 2011, 38:285-288.
7. Valtysdottir S.T., Wide L., Hallgren R. Low serum dehydroepiandrosterone sulfate in women with primary Sjogren's syndrome as an isolated sign of impaired HPA axis function. The Journal of Rheumatology 2001, 28:1259-1265.
8. Valtysdottir S.T., Wide L., Hallgren R. Mental wellbeing and quality of sexual life in women with primary Sjogren's syndrome are related to circulating dehydroepiandrosterone sulphate. Annals of the Rheumatic Diseases 2003, 62:875-879.
9. Hartkamp A., Geenen R., Kruize A.A., Bossema E.R., Godaert G.L., Bootsma H., et al. Serum dehydroepiandrosterone sulphate levels and laboratory and clinical parameters indicating expression of disease are not associated with fatigue, well-being and functioning in patients with primary Sjogren's syndrome. Clinical and Experimental Rheumatology 2011, 29:318-321.
10. Pillemer S.R., Brennan M.T., Sankar V., Leakan R.A., Smith J.A., Grisius M., et al. Pilot clinical trial of dehydroepiandrosterone (DHEA) versus placebo for Sjogren's syndrome. Arthritis and Rheumatism 2004, 51:601-604.
11. Virkki L.M., Porola P., Forsblad-d'Elia H., Valtysdottir S., Solovieva S.A., Konttinen Y.T. Dehydroepiandrosterone (DHEA) substitution treatment for severe fatigue in DHEA-deficient patients with primary Sjogren's syndrome. Arthritis Care & Research 2010, 62:118-124.
12. Hartkamp A., Geenen R., Godaert G.L., Bootsma H., Kruize A.A., Bijlsma J.W., et al. Effect of dehydroepiandrosterone administration on fatigue, well-being, and functioning in women with primary Sjogren syndrome: a randomised controlled trial. Annals of the Rheumatic Diseases 2008, 67:91-97.
13. Porola P., Straub R.H., Virkki L.M., Konttinen Y.T., Nordstrom D.C. Failure of oral DHEA treatment to increase local salivary androgen outputs of female patients with Sjogren's syndrome. Scandinavian Journal of Rheumatology 2011, 40:387-390.
14. Johnson E.O., Skopouli F.N., Moutsopoulos H.M. Neuroendocrine manifestations in Sjogren's syndrome. Rheumatic Diseases Clinics of North America 2000, 26:927-949.
15. Imrich R., Nikolov N.P., Bebris L., Alevizos I., Goldstein D.S., Holmes C.S., et al. Adrenomedullary response to glucagon in patients with primary Sjogren's syndrome. Cellular and Molecular Neurobiology 2012.
16. Ishimaru N., Arakaki R., Watanabe M., Kobayashi M., Miyazaki K., Hayashi Y. Development of autoimmune exocrinopathy resembling Sjogren's syndrome in estrogen-deficient mice of healthy background. The American Journal of Pathology 2003, 163:1481-1490.
17. Ishimaru N., Arakaki R., Yoshida S., Yamada A., Noji S., Hayashi Y. Expression of the retinoblastoma protein RbAp48 in exocrine glands leads to Sjogren's syndrome-like autoimmune exocrinopathy. The Journal of Experimental Medicine 2008, 205:2915-2927.
18. Shim G.J., Warner M., Kim H.J., Andersson S., Liu L., Ekman J., et al. Aromatase-deficient mice spontaneously develop a lymphoproliferative autoimmune disease resembling Sjogren's syndrome. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:12628-12633.
19. Manoussakis M.N., Tsinti M., Kapsogeorgou E.K., Moutsopoulos H.M. The salivary gland epithelial cells of patients with primary Sjogren's syndrome manifest significantly reduced responsiveness to 17beta-estradiol. Journal of Autoimmunity 2012.
20. Tsinti M., Kassi E., Korkolopoulou P., Kapsogeorgou E., Moutsatsou P., Patsouris E., et al. Functional estrogen receptors alpha and beta are expressed in normal human salivary gland epithelium and apparently mediate immunomodulatory effects. European Journal of Oral Sciences 2009, 117:498-505.
21. Schot L.P., Verheul H.A., Schuurs A.H. Effect of nandrolone decanoate on Sjogren's syndrome like disorders in NZB/NZW mice. Clinical and Experimental Immunology 1984, 57:571-574.
22. Sullivan D.A., Belanger A., Cermak J.M., Berube R., Papas A.S., Sullivan R.M., et al. Are women with Sjogren's syndrome androgen-deficient?. The Journal of Rheumatology 2003, 30:2413-2419.
23. Laine M., Porola P., Udby L., Kjeldsen L., Cowland J.B., Borregaard N., et al. Low salivary dehydroepiandrosterone and androgen-regulated cysteine-rich secretory protein 3 levels in Sjogren's syndrome. Arthritis and Rheumatism 2007, 56:2575-2584.
24. Forsblad-d'Elia H., Carlsten H., Labrie F., Konttinen Y.T., Ohlsson C. Low serum levels of sex steroids are associated with disease characteristics in primary Sjogren's syndrome; supplementation with dehydroepiandrosterone restores the concentrations. The Journal of Clinical Endocrinology and Metabolism 2009, 94:2044-2051.
25. Konttinen Y.T., Fuellen G., Bing Y., Porola P., Stegaev V., Trokovic N., et al. Sex steroids in Sjogren's syndrome. Journal of Autoimmunity 2012.
26. Spaan M., Porola P., Laine M., Rozman B., Azuma M., Konttinen Y.T. Healthy human salivary glands contain a DHEA-sulphate processing intracrine machinery, which is deranged in primary Sjogren's syndrome. Journal of Cellular and Molecular Medicine 2009, 13:1261-1270.
27. Shelly S., Boaz M., Orbach H. Prolactin and autoimmunity. Autoimmunity Reviews 2012, 11:A465-A470.
28. Jara L.J., Medina G., Saavedra M.A., Vera-Lastra O., Navarro C. Prolactin and autoimmunity. Clinical Reviews in Allergy and Immunology 2011, 40:50-59.
29. Steinfeld S., Rommes S., Francois C., Decaestecker C., Maho A., Appelboom T., et al. Big prolactin 60 kDa is overexpressed in salivary glandular epithelial cells from patients with Sjogren's syndrome. Laboratory investigation. A Journal of Technical Methods and Pathology 2000, 80:239-247.
30. Haga H.J., Rygh T. The prevalence of hyperprolactinemia in patients with primary Sjogren's syndrome. The Journal of Rheumatology 1999, 26:1291-1295.
31. Allen S.H., Sharp G.C., Wang G., Conley C., Takeda Y., Conroy S.E., et al. Prolactin levels and antinuclear antibody profiles in women tested for connective tissue disease. Lupus 1996, 5:30-37.
32. El Miedany Y.M., Ahmed I., Moustafa H., El Baddini M. Hyperprolactinemia in Sjogren's syndrome: a patient subset or a disease manifestation?. Joint Bone Spine 2004, 71:203-208.
33. Alfaris N., Curiel R., Tabbara S., Irwig M.S. Autoimmune thyroid disease and Sjogren syndrome. Journal of Clinical Rheumatology 2010, 16:146-147.
34. Tektonidou M.G., Anapliotou M., Vlachoyiannopoulos P., Moutsopoulos H.M. Presence of systemic autoimmune disorders in patients with autoimmune thyroid diseases. Annals of the Rheumatic Diseases 2004, 63:1159-1161.
35. Mavragani C.P., Skopouli F.N., Moutsopoulos H.M. Increased prevalence of antibodies to thyroid peroxidase in dry eyes and mouth syndrome or sicca asthenia polyalgia syndrome. The Journal of Rheumatology 2009, 36:1626-1630.
36. Kerr M., Lee A., Wang P.L., Purushotham K.R., Chegini N., Yamamoto H., et al. Detection of insulin and insulin-like growth factors I and II in saliva and potential synthesis in the salivary glands of mice. Effects of type 1 diabetes mellitus. Biochemical Pharmacology 1995, 49:1521-1531.
37. Kobayashi S., Kamino Y., Hiratsuka K., Kiyama-Kishikawa M., Abiko Y. Age-related changes in IGF-1 expression in submandibular glands of senescence-accelerated mice. Journal of Oral Science 2004, 46:119-125.
38. Mitsui R., Fujita-Yoshigaki J., Narita T., Matsuki-Fukushima M., Satoh K., Qi B., et al. Maintenance of paracellular barrier function by insulin-like growth factor-I in submandibular gland cells. Archives of Oral Biology 2010, 55:963-969.
39. Katz J., Stavropoulos F., Cohen D., Robledo J., Stewart C., Heft M. IGF-1 and insulin receptor expression in the minor salivary gland tissues of Sjogren's syndrome and mucoceles-immunohistochemical study. Oral Diseases 2003, 9:7-13.
40. Emamian E.S., Leon J.M., Lessard C.J., Grandits M., Baechler E.C., Gaffney P.M., et al. Peripheral blood gene expression profiling in Sjogren's syndrome. Genes and Immunity 2009, 10:285-296.
41. Mavragani C.P., Crow M.K. Activation of the type I interferon pathway in primary Sjogren's syndrome. Journal of Autoimmunity 2010, 35:225-231.
42. Karsh J., Pavlidis N., Weintraub B.D., Moutsopoulos H.M. Thyroid disease in Sjogren's syndrome. Arthritis and Rheumatism 1980, 23:1326-1329.
43. Kelly C.A., Foster H., Pal B., Gardiner P., Malcolm A.J., Charles P., et al. Primary Sjogren's syndrome in north east England-a longitudinal study. Br J Rheumatol 1991, 30:437-442.
44. Hansen B.U., Ericsson U.B., Henricsson V., Larsson A., Manthorpe R., Warfvinge G. Autoimmune thyroiditis and primary Sjogren's syndrome: clinical and laboratory evidence of the coexistence of the two diseases. Clinical and Experimental Rheumatology 1991, 9:137-141.
45. Bouanani M., Bataille R., Piechaczyk M., Salhi S.L., Pau B., Bastide M. Autoimmunity to human thyroglobulin. Respective epitopic specificity patterns of anti-human thyroglobulin autoantibodies in patients with Sjogren's syndrome and patients with Hashimoto's thyroiditis. Arthritis and Rheumatism 1991, 34:1585-1593.
46. Foster H., Fay A., Kelly C., Charles P., Walker D., Griffiths I. Thyroid disease and other autoimmune phenomena in a family study of primary Sjogren's syndrome. Br J Rheumatol 1993, 32:36-40.
47. Perez B., Kraus A., Lopez G., Cifuentes M., Alarcon-Segovia D. Autoimmune thyroid disease in primary Sjogren's syndrome. Am J Med 1995, 99:480-484.
48. Punzi L., Ostuni P.A., Betterle C., De Sandre P., Botsios C., Gambari P.F. Thyroid gland disorders in primary Sjogren's syndrome. Rev Rhum Engl Ed 1996, 63:809-814.
49. Davidson B.K., Kelly C.A., Griffiths I.D. Primary Sjogren's syndrome in the North East of England: a long-term follow-up study. Rheumatology (Oxford, England) 1999, 38:245-253.
50. Ramos-Casals M., Garcia-Carrasco M., Cervera R., Gaya J., Halperin I., Ubieto I., et al. Thyroid disease in primary Sjogren syndrome. Study in a series of 160 patients. Medicine (Baltimore) 2000, 79:103-108.
51. D'Arbonneau F., Ansart S., Le Berre R., Dueymes M., Youinou P., Pennec Y.L. Thyroid dysfunction in primary Sjogren's syndrome: a long-term followup study. Arthritis and Rheumatism 2003, 49:804-809.
52. Tunc R., Gonen M.S., Acbay O., Hamuryudan V., Yazici H. Autoimmune thyroiditis and anti-thyroid antibodies in primary Sjogren's syndrome: a case-control study. Annals of the Rheumatic Diseases 2004, 63:575-577.
53. Lazarus M.N., Isenberg D.A. Development of additional autoimmune diseases in a population of patients with primary Sjogren's syndrome. Annals of the Rheumatic Diseases 2005, 64:1062-1064.
54. Zeher M., Horvath I.F., Szanto A., Szodoray P. Autoimmune thyroid diseases in a large group of Hungarian patients with primary Sjogren's syndrome. Thyroid 2009, 19:39-45.
55. Youinou P., Haralampos M. Moutsopoulos: a lifetime in autoimmunity. Journal of Autoimmunity 2010, 35:171-175.
56. Gershwin M.E., Shoenfeld Y. Chella David: a lifetime contribution in translational immunology. Journal of Autoimmunity 2011, 37:59-62.
57. Mackay I.R., Leskovsek N.V., Rose N.R. The odd couple: a fresh look at autoimmunity and immunodeficiency. Journal of Autoimmunity 2010, 35:199-205.
58. Rose N.R. The genetics of autoimmune thyroiditis: the first decade. Journal of Autoimmunity 2011, 37:88-94.